Eran Eden, (right) co-founder and CEO of MeMed and Kfir Oved, co-founder and CTO, with their company’s MeMed BV blood test kit. Photo: Handout
Eran Eden, (right) co-founder and CEO of MeMed and Kfir Oved, co-founder and CTO, with their company’s MeMed BV blood test kit. Photo: Handout
Start-ups

Li Ka-shing-backed Israeli biotech start-up’s test to distinguish bacterial and viral infections wins US FDA approval

  • The US Food and Drug Administration approves the first test that can accurately identify the nature of infection in 15 minutes
  • Doctors say MeMed’s test will help cut unnecessary prescriptions of antibiotics

Eran Eden, (right) co-founder and CEO of MeMed and Kfir Oved, co-founder and CTO, with their company’s MeMed BV blood test kit. Photo: Handout
Eran Eden, (right) co-founder and CEO of MeMed and Kfir Oved, co-founder and CTO, with their company’s MeMed BV blood test kit. Photo: Handout
READ FULL ARTICLE